Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil

Abstract Background A rare phenotype of clinical non-progressors to AIDS is not well understood and the new protocol for universal treatment, may block the understanding of viral control thus it is crucial to define this controversial group. Methods A cohort of 30 persons followed a criteria for vir...

Full description

Bibliographic Details
Main Authors: Samara Tatielle M. Gomes, Érica R. Gomes, Mike B. dos Santos, Sandra S. Lima, Maria Alice F. Queiroz, Luiz Fernando A. Machado, Izaura M. V. Cayres-Vallinoto, Antonio Carlos R. Vallinoto, Marluísa de O. Guimarães Ishak, Ricardo Ishak
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-017-2491-9
id doaj-f4da078559784f579e32c6448692f7a0
record_format Article
spelling doaj-f4da078559784f579e32c6448692f7a02020-11-25T03:53:46ZengBMCBMC Infectious Diseases1471-23342017-06-0117111310.1186/s12879-017-2491-9Immunological and virological characterization of HIV-1 viremia controllers in the North Region of BrazilSamara Tatielle M. Gomes0Érica R. Gomes1Mike B. dos Santos2Sandra S. Lima3Maria Alice F. Queiroz4Luiz Fernando A. Machado5Izaura M. V. Cayres-Vallinoto6Antonio Carlos R. Vallinoto7Marluísa de O. Guimarães Ishak8Ricardo Ishak9Federal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryFederal University of Para, Institute of Biological Sciences, Virus LaboratoryAbstract Background A rare phenotype of clinical non-progressors to AIDS is not well understood and the new protocol for universal treatment, may block the understanding of viral control thus it is crucial to define this controversial group. Methods A cohort of 30 persons followed a criteria for viremia control groups 1 (VC1; n = 2) and 2 (VC2; n = 7) and non-viral controllers (NC; n = 21) including number of years of diagnosis, LTCD4+, LTCD8+ counts, plasma viral load and the absence of ART; 241 uninfected control persons were matched to age and sex. Infected persons were regularly examined and submitted to two or three annual laboratory measurements. Polymorphisms and allele frequencies of CCR5Δ32 and SDF1–3’A were detected in the genomic DNA. Plasma levels of cytokines (IL-2, IL-4, IL-5, IL-9, IL-10, IL-13, IL-17 and IFN-y) were measured. Results The group investigated is originated from a miscigenetic population and demographic and social characteristics were not significantly relevant. LTCD4+ median values were higher among VC than NC, but significantly lower than uninfected controls. Evolution of LTCD4+ and LTCD8+ counts, showed a slight increase of LTCD4+ among VC, but a significant decrease in the NC. The percentage of annual change in LTCD4+ was also significantly different between the groups. LTCD4+/LTCD8+ ratio was inverted but not significant among the VC, thus the ratio may be a useful biomarker for the VC. A clear signature indicated a change from Th1 to Th2 cytokine profiles from VC to NC, respectively. Conclusions The knowledge of viral controllers characteristics in different population groups is important to define a strict universal definition for the sake of learning about the pathogenesis of HIV-1. Data on LTCD4+ seems to be stable and repetitive from published data, but the LTCD8+ response and the significance of LTCD4+/LTCD8+ ratio values are in need to further exploration as biomarkers. The change from Th1 to Th2 cytokine profile may help to design and adjust specific treatment protocols for the group.http://link.springer.com/article/10.1186/s12879-017-2491-9HIV-1Viral controllersElite controllersCytokinesCCR5SDF1
collection DOAJ
language English
format Article
sources DOAJ
author Samara Tatielle M. Gomes
Érica R. Gomes
Mike B. dos Santos
Sandra S. Lima
Maria Alice F. Queiroz
Luiz Fernando A. Machado
Izaura M. V. Cayres-Vallinoto
Antonio Carlos R. Vallinoto
Marluísa de O. Guimarães Ishak
Ricardo Ishak
spellingShingle Samara Tatielle M. Gomes
Érica R. Gomes
Mike B. dos Santos
Sandra S. Lima
Maria Alice F. Queiroz
Luiz Fernando A. Machado
Izaura M. V. Cayres-Vallinoto
Antonio Carlos R. Vallinoto
Marluísa de O. Guimarães Ishak
Ricardo Ishak
Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
BMC Infectious Diseases
HIV-1
Viral controllers
Elite controllers
Cytokines
CCR5
SDF1
author_facet Samara Tatielle M. Gomes
Érica R. Gomes
Mike B. dos Santos
Sandra S. Lima
Maria Alice F. Queiroz
Luiz Fernando A. Machado
Izaura M. V. Cayres-Vallinoto
Antonio Carlos R. Vallinoto
Marluísa de O. Guimarães Ishak
Ricardo Ishak
author_sort Samara Tatielle M. Gomes
title Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
title_short Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
title_full Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
title_fullStr Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
title_full_unstemmed Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
title_sort immunological and virological characterization of hiv-1 viremia controllers in the north region of brazil
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2017-06-01
description Abstract Background A rare phenotype of clinical non-progressors to AIDS is not well understood and the new protocol for universal treatment, may block the understanding of viral control thus it is crucial to define this controversial group. Methods A cohort of 30 persons followed a criteria for viremia control groups 1 (VC1; n = 2) and 2 (VC2; n = 7) and non-viral controllers (NC; n = 21) including number of years of diagnosis, LTCD4+, LTCD8+ counts, plasma viral load and the absence of ART; 241 uninfected control persons were matched to age and sex. Infected persons were regularly examined and submitted to two or three annual laboratory measurements. Polymorphisms and allele frequencies of CCR5Δ32 and SDF1–3’A were detected in the genomic DNA. Plasma levels of cytokines (IL-2, IL-4, IL-5, IL-9, IL-10, IL-13, IL-17 and IFN-y) were measured. Results The group investigated is originated from a miscigenetic population and demographic and social characteristics were not significantly relevant. LTCD4+ median values were higher among VC than NC, but significantly lower than uninfected controls. Evolution of LTCD4+ and LTCD8+ counts, showed a slight increase of LTCD4+ among VC, but a significant decrease in the NC. The percentage of annual change in LTCD4+ was also significantly different between the groups. LTCD4+/LTCD8+ ratio was inverted but not significant among the VC, thus the ratio may be a useful biomarker for the VC. A clear signature indicated a change from Th1 to Th2 cytokine profiles from VC to NC, respectively. Conclusions The knowledge of viral controllers characteristics in different population groups is important to define a strict universal definition for the sake of learning about the pathogenesis of HIV-1. Data on LTCD4+ seems to be stable and repetitive from published data, but the LTCD8+ response and the significance of LTCD4+/LTCD8+ ratio values are in need to further exploration as biomarkers. The change from Th1 to Th2 cytokine profile may help to design and adjust specific treatment protocols for the group.
topic HIV-1
Viral controllers
Elite controllers
Cytokines
CCR5
SDF1
url http://link.springer.com/article/10.1186/s12879-017-2491-9
work_keys_str_mv AT samaratatiellemgomes immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT ericargomes immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT mikebdossantos immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT sandraslima immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT mariaalicefqueiroz immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT luizfernandoamachado immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT izauramvcayresvallinoto immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT antoniocarlosrvallinoto immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT marluisadeoguimaraesishak immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
AT ricardoishak immunologicalandvirologicalcharacterizationofhiv1viremiacontrollersinthenorthregionofbrazil
_version_ 1724476732933668864